Japanese and Chinese applicants show relatively high specialisation in white biotech patents, while UK and US applicants are relatively specialised in red biotech patents.
Japanese and Chinese applicants show relatively high specialisation in white biotech patents, while UK and US applicants are relatively specialised in red biotech patents. While the EU as a single region does not appear to be specialised in a specific biotechnology, at Member State level Germany and Denmark are specialised in white biotech, France and Italy in red biotech, and the Netherlands in green biotech.